February Health Impact Report 2010

Similar documents
October 2011 Monthly Health Impact Report

Impact Dashboard - August 2014

Impact Dashboard - October 2014

impact dashboard - september 2018

impact dashboard - august 2018

impact dashboard - june 2018

impact dashboard - may 2018

impact dashboard year-end with 2017 coefficients

Annex 2 A. Regional profile: West Africa

Eligibility List 2018

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

2015 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

Sexual and reproductive health care: A comparison of providers and delivery points between the African Region and other regions

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

2006 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

Comparative Analyses of Adolescent Nutrition Indicators

2002 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

UNAIDS Office on AIDS, Security and Humanitarian Response; Initiative on HIV/AIDS and Uniformed Services, with special emphasis on young recruits

ANNEX 3: Country progress indicators

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved

Global Fund Results Fact Sheet Mid-2011

Tipping the dependency

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

2007 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

מדינת ישראל. Tourist Visa Table

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

Global Fund ARV Fact Sheet 1 st June, 2009

THE CARE WE PROMISE FACTS AND FIGURES 2017

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

WORLD COUNCIL OF CREDIT UNIONS 2017 STATISTICAL REPORT

2010 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

Global Fund Mid-2013 Results

SGCEP SCIE 1121 Environmental Science Spring 2012 Section Steve Thompson:

2009 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

Various interventions for controlling sexually transmitted infections have proven effective, including the syndromic

JOINT TB AND HIV PROGRAMMING

Outcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts

10 Years of Laboratory Capacity Building. September 6-11 th, 2015 Les Pensieres, Veyrier-du-Lac, France

Presentation by Dr Philippe Douste-Blazy. Chair of UNITAID Special Representative of the UN SG for Innovative Financing for Development

UNAIDS 2013 AIDS by the numbers

Main global and regional trends

Diagnostic Procurement The Clinton Foundation HIV/AIDS Initiative

Family Planning: Succeeding in Meeting Needs To Make a Better World. Amy Tsui April 12, 2011

Financing malaria control

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, 2000)

Donor Support for Contraceptives and Condoms for STI/HIV Prevention

Lessons learned from the IeDEA West Africa Collaboration

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

THE FUTURE OF ADULT MORTALITY UNDER THE AIDS THREAT: ESTIMATING AND PROJECTING INCIDENCE; PROJECTING MORTALITY WITH HIV/AIDS *

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

AIDS in Africa. An Update. Basil Reekie

S P. Understanding heterogeneity in HIV infection and efficiency in HIV progam responses

BCG. and your baby. Immunisation. Protecting babies against TB. the safest way to protect your child

D TA companion & Scorecard. to the UNICEF Gender Action Plan. May 2016

Challenges and Opportunities to Optimizing the HIV Care Continuum Can We Test and Treat Enough People to Make a Seismic Difference by 2030?

Maternal Deaths Disproportionately High in Developing Countries

Why Invest in Nutrition?

WHO report highlights violence against women as a global health problem of epidemic proportions

Hearing loss in persons 65 years and older based on WHO global estimates on prevalence of hearing loss

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

Methodological issues in the use of anthropometry for evaluation of nutritional status

Update on progress of MPP sublicensees

CALLING ABROAD PRICES FOR EE SMALL BUSINESS PLANS

GLOBAL RepORt UNAIDS RepoRt on the global AIDS epidemic

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

Sourcing of ARVs & HIV diagnostics. Procurement for Impact P4i

The Global HIV/AIDS Epidemic, risk factors for transmission. and Global response. Training Course in Sexual and Reproductive Health Research 2014

DATA COMPANION & & SCORECARD. to the UNICEF Gender Action Plan. May 2017

IMMUNIZATION VACCINES & EMERGENCIES

ICM: Trade-offs in the fight against HIV/AIDS

Expert Group Meeting on Strategies for Creating Urban Youth Employment: Solutions for Urban Youth in Africa

Global summary of the AIDS epidemic, December 2007

What is this document and who is it for?

Seizures of ATS (excluding ecstasy ), 2010

ACCESS 7. TOWARDS UNIVERSAL ACCESS: THE WAY FORWARD

Epidemiology and economics: modelling the scenarios for the end of AIDS

Rotavirus vaccines: Issues not fully addressed in efficacy trials

HIV and development challenges for Africa Catherine Hankins, Associate Director & Chief Scientific Adviser to UNAIDS

IX. IMPROVING MATERNAL HEALTH: THE NEED TO FOCUS ON REACHING THE POOR. Eduard Bos The World Bank

Children in Africa. Key statistics on child survival, protection and development

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

HIV in Women: A Global View of the HIV Epidemic

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

MATERNAL, NEWBORN, AND CHILD HEALTH

ADMINISTRATIVE AND FINANCIAL MATTERS. Note by the Executive Secretary * CONTENTS. Explanatory notes Tables. 1. Core budget

511,000 (57% new cases) ~50,000 ~30,000

Update from GAVI Aurelia Nguyen

Global malaria mortality between 1980 and 2010: a systematic analysis

Global Measles and Rubella Update. April 2018

Transcription:

February Health Impact Report 1,391,742 Feb'10 DALYs: 7.5% of strategic target goal is 14% 26% decrease from Feb'09 Feb' 10 DALYs include: :: 1,350,675 product s :: 41,067 BCC DALYs todate in 9 countries: Cambodia, El Salvador, Honduras, India, Kenya, Laos, Nicaragua, Russia, and South Africa (see R&M KIX for specific behaviour change behind the impact) Feb' 10 CYPs: :: 2,036,171 CYPs, 3% decrease from Feb' 09 Starting Feb' 10, two new metrics have been included in the Health Impact report package: :: Price to Consumer :: Trade Margin The reason we have these two new metrics is to regularly monitor the price P and encourage more active price management. The two new metrics are introduced for male condoms only because male condoms are the biggest DALY producers among sold products, and our most common, and thus comparable, product. :: To draw attention to those brands that are sold at significantly under average prices, we flagged brand prices that are 8 (or less) of the PSI regional average consumer price. :: To highlight where we might increase our cost recovery by reducing trade margins, we flagged brands that offer a total trade margin (consumer price less lowest trade price) of 12 of more of the PSI regional average trade margin. :: The February Health Impact Report does not include program targets because they are not complete yet. We will include them in the March Health Impact Report if the coutry programs have finalized them by then. :: Strategic Target, YearEnd Performance and Program Estimate DALYs 24,000,000 20,570,714 20,000,000 18,513,643 16,000,000 12,000,000 8,000,000 10,285,357 10,285,357 12,342,429 9,538,469 14,399,500 13,400,382 16,456,572 15,208,244 9,631,837 (annualized) 4,000,000 Strategic Target YearEnd Performance 2006 2007 2008 2011 This report was produced with DALY translation model version 13. February Health Impact Report Executive Summary Page 1

:: s Averted by Region & Health Area (% Change from Prior Year ) All regions except Latin America & Caribbean experienced significant drop relative to Feb' 09. :: WCA: decrease in malaria nets distribution in Mali, Nigeria and CongoKinshasa :: EA: decrease in malaria nets distribution in Mozambique and Malwi; KO123 tab (with and without net) in Tanzania :: SA: decrease in Permanets distribution in Zambia; VCT clients in Zimbabwe and condom in South Africa :: Asia & EE: decrease in VSC and TB DOTS in Pakistan; condom, OCs and ORS in India DALYs 900,000 800,000 700,000 62% Child Survival Malaria Control 600,000 500,000 46% 15% 4 35% Reproductive Health HIV & TB 400,000 300,000 29% 16% 15% 25% 200,000 100,000 2007 2008 2007 2008 2007 2008 2007 2008 2007 2008 West & Central Africa East Africa Southern Africa 5% 1% 81% Latin America and Caribbean 8% 7 16% Asia and Eastern Europe :: s Averted by Health Area & Region (% Change from Prior Year ) Feb'10 DALYs from all health areas except reproductive health dropped relative to Feb'09. :: Feb'10 HIV DALYs dropped relative to Feb'09 due to the decrease in VCT clients in Zimbabwe. :: Malaria Feb'10 DALYs dropped significantly relative to Feb'09 due to the decrease in malaria nets distribution in Mali, Mozambique and Malawi and KO 123 tab in Tanzania. :: Child survival Feb'10 DALYs dropped from Feb'09 because of the decrease in safe water products distribution in Ethiopia, Uganda and Zambia. :: Feb'10 reproductive health DALYs slighly increased from Feb'09 thanks to IUDs program in Nigeria. DALYs 1,000,000 900,000 96% 800,000 700,000 Asia and Eastern Europe 600,000 500,000 400,000 300,000 2% 15% 11% 2% 2 3% 42% 46% Latin America and Caribbean Southern Africa East Africa West and Central Africa 200,000 100,000 17% 39% 31% 2007 2008 2007 2008 2007 2008 2007 2008 HIV & TB Reproductive Health Malaria Control Child Survival February Health Impact Report Executive Summary Page 2

:: DALYs by Month by Region West & Central Africa and Southern Africa regions experienced a significant drop in Feb'10 DALYs relative to Jan'10 because of malaria net distribution campaigns in Rwanda (ITN) and Zimbabwe (Olyset) in Jan'10. DALYs 1,500,000 1,200,000 900,000 600,000 300,000 Asia and Eastern Europe East Africa West and Central Africa Southern Africa Latin America and Caribbean Mar' 09 Apr' 09 May' 09 Jun' 09 Jul' 09 Aug' 09 Sep' 09 Oct' 09 Nov' 09 Dec' 09 Jan' 10 Feb' 10 :: DALYs by Month by Health Area Feb' 10 DALYs for all health areas except malaria control increased from Jan'10. Malaria feb'10 DALYs dropped significantly from Jan'10 due to massive malaria net distribution campaigns in Rwanda in Jan'10. DALYs 2,500,000 2,000,000 1,500,000 1,000,000 500,000 Child Survival Mar' 09 Apr' 09 May' 09 Jun' 09 Jul' 09 Aug' 09 Sep' 09 Oct' 09 Nov' 09 Dec' 09 Jan' 10 Feb' 10 HIV & TB Reproductive Health Malaria Control February Health Impact Report Executive Summary Page 3

:: DALYs from Products Distributed for Free 43% of our DALYs are from free products. Malaria nets account for 6 of free DALYs. DALYs 10,000,000 Free Permanet 8,000,000 Free Olyset Free Condom Free KO123 with net 54% 6,000,000 Free ITN Free KO123 Free Retreatment 47% Free Basic Care Package 4,000,000 Free VCT Single Free IconMaxx Free Safe Water Solution 43% 2,000,000 Free Malaria PPT (ACT) Free IUD Free Implant 5 Free VCT Couple 1 9% Other Free Products 23% 28% 0 2004 2005 2006 2007 2008 Annualized :: Change in product DALYs ( vs. ) Condom DALYs down (Nigeria & South Africa) VCT DALYs down (Zimbabwe, Mozambique & Zambia) 25 HIV & TB 2,738% 1,165% 839% 485% 257% OCs DALYs down (India & Nigeria) Reproductive Health 20 15 10 5 5 87% 39% 27% 14% 4% 27% 36% 41% 58% 59% 66% 4% 6% 8% 2 36% 78% 10 10 Free Female Condom Basic Care Pakage MC (HIVNegative) MC (HIVUnknown) Condom STI Kit+ Female Condom Free Condom TB DOTS VCT Couple VCT Single + Preliminary figures for STI Kit until external review is done. Implant 5 IUD Injectable 3 Medical Abortion Injectable 1 Injectable 2 Multivit EC Iron Folic Tab Cycle Beads OCs Implant 3 Clean Delivery Kit VSC 20 Permanet DALYs down (Mali, Malawi & Nigeria) Olyset DALYs down (Mozambique) Malaria Control 535% 354% SWS DALYs down (Ethiopia, Uganda & Zambia) ORS DALYs down (India) Child Survival 15 13 10 5 3 34% 53% 6 86% 97% 16% 35% 51% 64% 8 10 5 10 ITN Malaria PPT (ACT) Olyset KO123 with net Malaria RDK LLIN KO123 Diarrhea Treatment Kit PUR ORS Safe Water Solution Water Treatment Tablets Sprinkles Pneumonia PPT Zinc February Health Impact Report Executive Summary Page 4

:: CYPs, Cases Averted and Deaths Averted CYPs, Cases and Deaths West and Central Africa East Africa Southern Africa Latin America and the Caribbean Asia and Eastern Europe PSI GLOBAL HIV & TB :: HIV Cases Averted 5,012 6,132 8,523 104 734 20,506 :: STI Deaths Averted 50 9 59 :: TB Deaths Averted 135 135 Reproductive Health :: CYP 631,675 284,844 274,316 89,782 755,553 2,036,171 :: Maternal Deaths Averted 1,085 514 484 14 413 2,511 :: Unintended Pregnancies Averted 186,796 84,797 81,663 15,669 132,035 500,960 Malaria Control :: Malaria Cases Averted 634,981 1,121,573 103,467 39,071 1,899,092 :: Malaria Deaths Averted 5,958 8,310 824 175 15,267 Child Survival :: Diarrhea Cases Averted 57,732 409,472 346,257 12,769 8,030 834,260 :: Diarrhea Deaths Averted 232 689 462 1 43 1,427 :: Nutrition Deaths Averted 10 10 :: Pneumonia Cases Averted 728 728 :: Pneumonia Deaths Averted 10 10 :: CYPs by Method (% Change from Prior Year) The largest increase between Feb' 09 and Feb' 10 was in IUD (Nigeria, Nepal, Pakistan and India). Million CYPs 16 14 12 10 Growth in CYPs by Product: 2000 to Annualized % Change over the prior year 18% 5% 7% 6% 4% 3% 14% 14% 1% VFT Free Female Condom Medical Abortion Implant 3 Injectable 1 Female Condom SDM (Cycle Beads) 8 24% Implant 5 6 4 19% Emergency Contraception VSC Injectable 2 2 Free Condom Injectable 3 2000 2001 2002 2003 2004 2005 2006 2007 2008 Annualized IUD OCs Condom February Health Impact Report Executive Summary Page 5

:: Product DALY HIV & TB Reproductive Health Malaria Control Child Survival Product ' 10 DALYs Absolute Change vs ' 09 % Change vs ' 09 Condom 550,307 (22,600) 4% 1) Condom 550,307 Basic Care Package* 29,897 27,534 1,165% 2) Olyset LLIN* 179,568 VCT Single* 29,731 (57,861) 66% 3) ITN* 139,775 Free Condom 27,668 (19,406) 41% 4) IUD* 71,832 Male Circumcision (HIVNegative)* 8,668 7,745 839% 5) Malaria PPT (ACT) 51,542 Female Condom 4,365 (2,475) 36% 6) Retreatment KO123 net* 48,579 VCT Couple* 4,147 (6,055) 59% 7) Permanet / Netprotect* 44,622 TB DOTS 4,020 (5,574) 58% 8) OCs 39,299 Male Circumcision (HIVUnknown)* 2,021 1,675 485% 9) Injectable 3 31,130 STI Kit + 1,481 (537) 27% 10) Safe Water Solution 30,940 Free Female Condom 460 444 2,738% 11) Basic Care Package* 29,897 Needle & Syringe 140 140 NA 12) VCT Single* 29,731 NVP (Mother and Baby) (1,240) 10 13) Free Condom 27,668 NVP (Mother Only) (272) 10 14) Implant 5* 14,852 IUD* 71,832 33,410 87% 15) Retreatment IconMaxx* 10,854 OCs 39,299 (9,877) 2 16) Male Circumcision (HIVNegative)* 8,668 Injectable 3 31,130 8,767 39% 17) ORS 8,236 Implant 5* 14,852 10,691 257% 18) Injectable 2 6,454 Injectable 2 6,454 29 19) Female Condom 4,365 Emergency Contraception 2,877 (121) 4% 20) VCT Couple* 4,147 Medical Abortion 1,763 377 27% 21) TB DOTS 4,020 SDM (Cycle Beads)* 1,578 (140) 8% 22) Diarrhea Treatment Kit 3,652 Misoprostol 939 939 NA 23) Water Treatment Tablets 2,925 Injectable 1 584 74 14% 24) Emergency Contraception 2,877 Clean Delivery Kit 485 (1,744) 78% 25) Retreatment KO123* 2,269 Iron Folic Acid Tablet 471 (28) 6% 26) Male Circumcision (HIVUnknown)* 2,021 Multivitamin 300 (1) 27) Medical Abortion 1,763 Implant 3* 167 (93) 36% 28) SDM (Cycle Beads)* 1,578 VSC* 0 (8,499) 10 29) STI Kit + 1,481 Olyset LLIN* 179,568 (90,764) 34% 30) Malaria RDK 1,430 ITN* 139,775 117,747 535% 31) Sprinkles 1,193 Malaria PPT (ACT) 51,542 (21,835) 3 32) Misoprostol 939 Retreatment KO123 net* 48,579 (54,937) 53% 33) Retreatment 720 Permanet / Netprotect* 44,622 (279,780) 86% 34) PUR 593 Retreatment IconMaxx* 10,854 10,854 NA 35) Injectable 1 584 Retreatment KO123* 2,269 (65,014) 97% 36) Clean Delivery Kit 485 Malaria RDK 1,430 (2,108) 6 37) Iron Folic Acid Tablet 471 Retreatment 720 248 52% 38) Free Female Condom 460 Safe Water Solution 30,940 (16,547) 35% 39) Pneumonia PPT 333 ORS 8,236 (1,570) 16% 40) Multivitamin 300 Diarrhea Treatment Kit 3,652 2,847 354% 41) Implant 3* 167 Water Treatment Tablets 2,925 (3,046) 51% 42) Needle & Syringe 140 Sprinkles 1,193 (2,114) 64% 43) Infant Fortified Food PUR 593 335 13 44) NVP (Mother and Baby) Pneumonia PPT 333 (1,371) 8 45) NVP (Mother Only) Zinc 0 (169) 10 46) VSC* Infant Fortified Food 0 0 NA 47) Zinc Deworming Tablets 1 NA NA NA 48) Deworming Tablets 1 N/A * Multiyear protection product + Preliminary figures for STI Kit until external review is done. 1 A DALY for Deworming Tablets will be developed in if Deworming Tablets are still being distributed then. No. s Ranked by Product February Health Impact Report Executive Summary Page 6

:: Country DALY Asia and Eastern Europe Latin America and Caribbean Southern Africa East Africa West and Central Africa Country ' 10 DALYs Absolute Change vs % Change vs ' ' 09 09 No. s Ranked by Country Nigeria 196,208 (80,908) 29% 1) Kenya 273,182 Rwanda 140,495 122,132 665% 2) Nigeria 196,208 CongoKinshasa 27,311 (13,269) 33% 3) Rwanda 140,495 Cameroon 18,559 1,968 12% 4) Zimbabwe 133,250 Mali 14,879 (122,932) 89% 5) Tanzania 77,677 Benin 13,540 11,090 453% 6) Mozambique 59,705 Togo 13,239 2,633 25% 7) Pakistan 55,944 Burkina Faso 10,191 555 6% 8) South Africa 48,689 Guinea 7,204 1,887 35% 9) Zambia 44,280 Burundi 1,569 266 2 10) Uganda 43,563 Cote d'ivoire 1,140 (910) 44% 11) Malawi 39,008 Haiti 760 (2,054) 73% 12) India 35,278 Liberia 111 111 NA 13) CongoKinshasa 27,311 C.A.R. 8 (857) 99% 14) Cameroon 18,559 Kenya 273,182 18,146 7% 15) Myanmar 14,955 Tanzania 77,677 (108,055) 58% 16) Mali 14,879 Mozambique 59,705 (95,527) 62% 17) Swaziland 14,519 Uganda 43,563 911 2% 18) Benin 13,540 Malawi 39,008 (57,748) 6 19) Togo 13,239 Sudan 8,093 3,902 93% 20) Madagascar 12,937 Ethiopia 2,446 (13,895) 85% 21) Cambodia 10,632 Somaliland 60 (1,953) 97% 22) Lesotho 10,406 Angola 0 (16,829) 10 23) Burkina Faso 10,191 Zimbabwe 133,250 (7,902) 6% 24) Sudan 8,093 South Africa 48,689 (38,424) 44% 25) Guinea 7,204 Zambia 44,280 (31,665) 42% 26) Botswana 5,118 Swaziland 14,519 3,489 32% 27) Nepal 4,866 Madagascar 12,937 (8,722) 4 28) Namibia 3,044 Lesotho 10,406 (3,099) 23% 29) Ethiopia 2,446 Botswana 5,118 (4,190) 45% 30) Burundi 1,569 Namibia 3,044 (2,149) 41% 31) Guatemala 1,485 Guatemala 1,485 1,116 303% 32) Dominican Republic 1,183 Dominican Republic 1,183 111 1 33) Cote d'ivoire 1,140 El Salvador 932 791 561% 34) El Salvador 932 Nicaragua 665 183 38% 35) Vietnam 840 Paraguay 623 194 45% 36) Haiti 760 Panama 503 135 37% 37) Nicaragua 665 Honduras 276 20 8% 38) Paraguay 623 Costa Rica 83 35 73% 39) Panama 503 Mexico 31 24 388% 40) Honduras 276 Caribbean 8 8 NA 41) Laos 250 Belize 0 (20) 10 42) Kazakhstan 243 Pakistan 55,944 (11,898) 18% 43) Kyrgyzstan 232 India 35,278 (11,831) 25% 44) Thailand 142 Myanmar 14,955 763 5% 45) Liberia 111 Cambodia 10,632 (2,859) 21% 46) Romania 109 Nepal 4,866 3,416 236% 47) Tajikistan 97 Vietnam 840 (285) 25% 48) China 85 Laos 250 (80) 24% 49) Costa Rica 83 Kazakhstan 243 207 575% 50) Somaliland 60 Kyrgyzstan 232 37 19% 51) Mexico 31 Thailand 142 106 289% 52) Papua New Guinea 21 Romania 109 (78) 42% 53) Caribbean 8 Tajikistan 97 (42) 3 54) C.A.R. 8 China 85 (173) 67% 55) Belize 0 Papua New Guinea 21 2 1 56) Angola 0 Russia 0 0 NA 57) Russia 0 February Health Impact Report Executive Summary Page 7

:: PSI Country Programs West and Central Africa Benin Burkina Faso Burundi C.A.R. Cameroon CongoKinshasa Cote d Ivoire Guinea Haiti Liberia Mali Nigeria Rwanda Togo East Africa Angola Ethiopia Kenya Malawi Mozambique Somaliland Sudan Tanzania Uganda Southern Africa Botswana Lesotho Madagascar Namibia South Africa Swaziland Zambia Zimbabwe Latin America and the Caribbean Central America Belize Costa Rica El Salvador Guatemala Honduras Nicaragua Panama Caribbean Antigua Barbados Dominica Grenada Jamaica St. Kitss St. Lucia St. Martin St. Vincent Suriname Trinidad Other LAC countries Dominican Republic Mexico Paraguay Asia and Eastern Europe Asia Cambodia China India Kazakhstan Kyrgyzstan Laos Myanmar Nepal Pakistan Papua New Guinea Thailand Tajikistan Vietnam Eastern Europe Romania Russia February Health Impact Report Executive Summary Page 8

:: Products by Health Area HIV & TB Basic Care Package (BCP) Condom (Male Condom) Female Condom Free Condom (Free Male Condom) Free Female Condom Lubricants (A, B, C, D, E) Male Circumcision (HIVNegative)* Male Circumcision (HIVUnknown)* Needle & Syringe NVP (Mother and Baby) NVP (Mother Only) STI Kit + TB DOTS TB Prevention VCT Concordant Couple (HIVNegative)* VCT Concordant Couple (HIVPositive)* VCT Discordant Couple (HIVNegative)* VCT Discordant Couple (HIVPositive)* VCT Individual (HIVNegative)* VCT Individual (HIVPositive)* Reproductive Health Clean Delivery Kit (CDK) Condom (Male Condom) Cycle beads (SDM)* Emergency Contraception Female Condom Free Condom (Free Male Condom) Free Female Condom Intrauterine Device* Iron Folic Acid Hormonal Implant 3year* Hormonal Implant 5year* Injectable 1month Injectable 2month Injectable 3month Medical Abortion Misoprostol Multivitamin Oral Contraceptives Vaginal Foaming Tablets Voluntary Surgical Contraception (VSC)* Malaria Control Insecticide Treated Net (ITN)* Malaria PPT (ACT) Malaria PPT (NonACT) Malaria RDK (Rapid Diagnostic Kit) Netprotect* Olyset LLIN* Permanet LLIN* Retreatment Retreatment IconMaxx* Retreatment KO 123* Retreatment KO 123 Net* Child Survival Deworming Tablet 1 Diarrhea Treatment Kit (DTK) Infant Fortified Food ORS Pneumonia PPT PUR Safe Water Solution Sprinkle Water Treatment Tablets (Chlorine Tabs) Zinc * Product with multiyear protection + Preliminary figures for STI Kit until external review is done. 1 A DALY for Deworming Tablets will be developed in if Deworming Tablets are still being distributed then. Data for male circumcision, TB DOTS and VCT come from Health Service Database February Health Impact Report Executive Summary Page 9

:: Table of Contents I. Summary Tables CYPs, Cases, and Deaths Regional Summary 1 DALYs Report by Region 2 DALYs Report by Health Area 3 DALYs Report by Country 4 Distribution Report by Product 10 II. Regional Performance West and Central Africa 19 East Africa 47 Southern Africa 67 Latin America & Caribbean 87 Asia and Eastern Europe 111 III. Price to Consumer 139 IV. Trade Margin 149 February Health Impact Report

Summary Tables by Region, Health Area, Country and Product

CYPs, Cases, and Deaths by Region 1/ 2/ HIV & TB Reproductive Health Malaria Control Child Survival Cases STI Deaths TB Deaths CYP Maternal Deaths Unintended Pregnancies Malaria Cases Malaria Deaths Diarrhea Cases Diarrhea Deaths Nutrition Deaths Pneumonia Cases Pneumonia Deaths Sum of All Deaths West and Central Africa 5,012 631,675 1,085 186,796 634,981 5,958 57,732 232 7,275 East Africa 6,132 284,844 514 84,797 1,121,573 8,310 409,472 689 9,513 Southern Africa 8,523 50 274,316 484 81,663 103,467 824 346,257 462 1,820 Americas 104 89,782 14 15,669 12,769 1 15 Asia and Eastern Europe 734 9 135 755,553 413 132,034 39,071 175 8,030 43 10 728 10 796 Total 20,506 59 135 2,036,171 2,511 500,960 1,899,092 15,267 834,260 1,427 10 728 10 19,419 1 3001 3/23/ 4:28:28PM Page 1 of 1

Monthly DALY Report by Region Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved GRAND TOTAL 651,210 1,814,790 1,350,675 (26%) % West and Central Africa 190,537 525,503 445,214 (15)% 10 HIV & TB 55,719 113,436 97,259 (14)% 22% Reproductive Health 93,063 143,537 153,845 7% 35% Malaria Control 36,501 263,517 186,807 (29)% 42% Child Survival 5,254 5,014 7,303 46% 2% East Africa 279,189 774,781 503,733 (35)% 10 HIV & TB 90,242 126,603 149,308 18% 3 Reproductive Health 36,891 68,327 71,020 4% 14% Malaria Control 137,278 542,107 261,005 (52)% 52% Child Survival 14,779 37,744 22,400 (41)% 4% Southern Africa 113,752 364,904 272,243 (25)% 10 HIV & TB 84,686 232,422 175,387 (25)% 64% Reproductive Health 30,630 60,543 67,971 12% 25% Malaria Control (10,782) 52,648 13,668 (74)% 5% Child Survival 9,219 19,291 15,216 (21)% 6% Americas 3,180 3,190 5,789 81% 10 HIV & TB 986 1,461 2,006 37% 35% Reproductive Health 2,179 1,729 3,712 115% 64% Child Survival 15 71 31,002% 1% Asia and Eastern Europe 64,551 146,411 123,696 (16)% 10 HIV & TB 11,091 25,882 18,642 (28)% 15% Reproductive Health 49,252 106,395 96,486 (9)% 78% Malaria Control 2,965 6,678 5,690 (15)% 5% Child Survival 1,243 7,456 2,879 (61)% 2% 2 3007 3/23/ 4:33:07PM Page 1 of 1

Monthly DALY Report by Health Area Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved GRAND TOTAL 651,210 1,814,790 1,350,675 (26%) % HIV & TB 242,724 499,805 442,604 (11)% 10 West and Central Africa 55,719 113,436 97,259 (14)% 22 % East Africa 90,242 126,603 149,308 18% 34 % Southern Africa 84,686 232,422 175,387 (25)% 4 Americas 986 1,461 2,006 37% Asia and Eastern Europe 11,091 25,882 18,642 (28)% 4 % Reproductive Health 212,015 380,531 393,033 3% 10 West and Central Africa 93,063 143,537 153,845 7% 39 % East Africa 36,891 68,327 71,020 4% 18 % Southern Africa 30,630 60,543 67,971 12% 17 % Americas 2,179 1,729 3,712 115% 1 % Asia and Eastern Europe 49,252 106,395 96,486 (9)% 25 % Malaria Control 165,961 864,949 467,170 (46)% 10 West and Central Africa 36,501 263,517 186,807 (29)% 4 East Africa 137,278 542,107 261,005 (52)% 56 % Southern Africa (10,782) 52,648 13,668 (74)% 3 % Asia and Eastern Europe 2,965 6,678 5,690 (15)% 1 % Child Survival 30,510 69,505 47,869 (31)% 10 West and Central Africa 5,254 5,014 7,303 46% 15 % East Africa 14,779 37,744 22,400 (41)% 47 % Southern Africa 9,219 19,291 15,216 (21)% 32 % Americas 15 71 31,002% Asia and Eastern Europe 1,243 7,456 2,879 (61)% 6 % 3 3005 3/23/ 4:31:07PM Page 1 of 1

Monthly DALY Report by Country Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved GRAND TOTAL 651,210 1,814,790 1,350,675 (26%) % West and Central Africa 190,537 525,503 445,214 (15%) 10 % Benin 9,476 2,450 13,540 453 % 3% % HIV & TB 1,290 3,408 2,232 (35)% 1% Reproductive Health 4,123 2,890 6,819 136% 2% Malaria Control (4,815) 1 (100)% Child Survival 4,063 967 4,489 364% 1% Burkina Faso 5,141 9,637 10,191 6 % 2% % HIV & TB 1,902 3,790 3,852 2% 1% Reproductive Health 3,239 5,847 6,340 8% 1% Burundi 320 1,303 1,569 2 % % HIV & TB 60 518 119 (77)% Reproductive Health 64 766 150 (80)% Malaria Control 154 19 1,251 6,602% Child Survival 41 50 C.A.R. 5 865 8 (99)% % % HIV & TB 2 407 4 (99)% Reproductive Health 3 457 4 (99)% Malaria Control Cameroon 12,059 16,591 18,559 12 % 4% % HIV & TB 6,148 8,618 8,796 2% 2% Reproductive Health 5,471 7,385 7,911 7% 2% Malaria Control 382 543 1,605 196% Child Survival 57 44 246 459% CongoKinshasa 16,281 40,580 27,311 (33)% 6% % HIV & TB 6,138 6,614 10,542 59% 2% Reproductive Health 8,761 11,195 14,962 34% 3% Malaria Control 1,341 22,693 1,744 (92)% Child Survival 42 78 63 (19)% Cote d'ivoire 96 2,050 1,140 (44)% % % HIV & TB 29 1,008 346 (66)% Reproductive Health 30 148 223 51% Malaria Control 97 180 87% Child Survival 36 799 390 (51)% Guinea 4,938 5,317 7,204 35 % 2% % HIV & TB 127 457 272 (40)% Reproductive Health 4,675 3,574 6,611 85% 1% Malaria Control Child Survival 136 1,285 320 (75)% Haiti 760 2,815 760 (73)% % % HIV & TB 160 1,519 160 (89)% Reproductive Health 402 836 402 (52)% Malaria Control 280 (100)% Child Survival 198 180 198 1 Liberia 86 111 % % % HIV & TB 1 1 Reproductive Health 3006 3/23/ 4:32:10PM Page 1 of 6 4

Monthly DALY Report by Country Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved Child Survival 85 110 Mali 7,409 137,811 14,879 (89)% 3% % HIV & TB 956 1,300 1,686 3 Reproductive Health 6,368 9,135 13,100 43% 3% Malaria Control 41 127,376 41 (100)% Child Survival 45 52 Nigeria 119,996 277,116 196,208 (29)% 44% % HIV & TB 35,224 78,889 62,709 (21)% 14% Reproductive Health 53,950 94,538 86,242 (9)% 19% Malaria Control 30,347 102,210 46,059 (55)% 1 Child Survival 475 1,479 1,198 (19)% Rwanda 7,411 18,363 140,495 665 % 32% % HIV & TB 1,913 2,405 2,658 11% 1% Reproductive Health 1,625 2,076 2,277 1 1% Malaria Control 3,800 13,701 135,374 888% 3 Child Survival 74 181 185 3% Togo 6,558 10,605 13,239 25 % 3% % HIV & TB 1,770 4,503 3,883 (14)% 1% Reproductive Health 4,352 4,689 8,803 88% 2% Malaria Control 436 1,414 552 (61)% East Africa 279,189 774,781 503,733 (35%) 10 % Angola 16,829 (100)% % % HIV & TB 1,134 (100)% Reproductive Health 2,827 (100)% Malaria Control 12,376 (100)% Child Survival 492 (100)% Ethiopia 1,477 16,341 2,446 (85)% % % HIV & TB 144 2,208 234 (89)% Reproductive Health 328 4,661 533 (89)% Malaria Control 1 965 1 (100)% Child Survival 1,004 8,507 1,678 (80)% Kenya 151,627 255,037 273,182 7 % 54% % HIV & TB 31,577 6,454 35,161 445% 7% Reproductive Health 12,472 23,064 26,876 17% 5% Malaria Control 103,467 219,171 204,502 (7)% 41% Child Survival 4,112 6,347 6,644 5% 1% Malawi 30,576 96,755 39,008 (60)% 8% % HIV & TB 2,951 5,147 4,550 (12)% 1% Reproductive Health 1,168 1,919 1,779 (7)% Malaria Control 21,219 81,230 25,421 (69)% 5% Child Survival 5,238 8,459 7,257 (14)% 1% Mozambique 31,533 155,233 59,705 (62)% 12% % HIV & TB 21,274 44,220 39,185 (11)% 8% Reproductive Health 5,788 8,978 10,715 19% 2% Malaria Control 3,222 99,005 7,855 (92)% 2% Child Survival 1,248 3,030 1,950 (36)% Somaliland 41 2,012 60 (97)% % % 3006 3/23/ 4:32:30PM Page 2 of 6 5

Monthly DALY Report by Country Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved Malaria Control 1,940 (100)% Child Survival 41 72 60 (18)% Sudan 4,242 4,191 8,093 93 % 2% % HIV & TB 227 1,866 370 (80)% Reproductive Health 216 1,858 347 (81)% Malaria Control 2,480 5,612 1% Child Survival 1,319 467 1,764 278% Tanzania 39,831 185,731 77,677 (58)% 15% % HIV & TB 22,051 50,811 40,437 (20)% 8% Reproductive Health 13,468 21,444 22,196 4% 4% Malaria Control 3,234 112,132 13,186 (88)% 3% Child Survival 1,079 1,345 1,858 38% Uganda 19,862 42,652 43,563 2 % 9% % HIV & TB 12,018 14,763 29,372 99% 6% Reproductive Health 3,451 3,576 8,574 14 2% Malaria Control 3,655 15,287 4,427 (71)% 1% Child Survival 738 9,025 1,190 (87)% Southern Africa 113,752 364,904 272,243 (25%) 10 % Botswana 2,328 9,308 5,118 (45)% 2% % HIV & TB 1,763 5,718 3,863 (32)% 1% Reproductive Health 565 1,988 1,256 (37)% Malaria Control Child Survival 1,602 (100)% Lesotho 4,915 13,505 10,406 (23)% 4% % HIV & TB 4,166 12,174 8,827 (27)% 3% Reproductive Health 750 1,331 1,580 19% 1% Madagascar (2,911) 21,659 12,937 (40)% 5% % HIV & TB 377 1,817 1,646 (9)% 1% Reproductive Health 2,979 8,367 13,693 64% 5% Malaria Control (11,325) 5,605 (9,907) (277)% (4)% Child Survival 5,059 5,870 7,506 28% 3% Namibia 1,884 5,192 3,044 (41)% 1% % HIV & TB 1,005 2,399 1,282 (47)% Reproductive Health 336 801 428 (47)% Malaria Control 543 1,992 1,334 (33)% South Africa 25,060 87,113 48,689 (44)% 18% % HIV & TB 19,729 68,406 38,130 (44)% 14% Reproductive Health 5,331 18,707 10,558 (44)% 4% Swaziland 7,593 11,031 14,519 32 % 5% % HIV & TB 6,501 10,335 12,971 26% 5% Reproductive Health 1,092 690 1,548 124% 1% Child Survival 6 (100)% Zambia 22,736 75,944 44,280 (42)% 16% % HIV & TB 9,325 24,933 20,391 (18)% 7% Reproductive Health 9,504 9,091 17,402 91% 6% Malaria Control 32,313 (100)% Child Survival 3,907 9,608 6,487 (32)% 2% 3006 3/23/ 4:32:30PM Page 3 of 6 6

Monthly DALY Report by Country Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved Zimbabwe 52,147 141,152 133,250 (6)% 49% % HIV & TB 41,820 106,639 88,278 (17)% 32% Reproductive Health 10,074 19,569 21,508 1 8% Malaria Control 12,738 22,241 75% 8% Child Survival 253 2,205 1,223 (45)% Americas 3,180 3,190 5,789 81% 10 % Antigua 2 2 % % % HIV & TB Reproductive Health 1 1 Barbados 2 2 % % % HIV & TB 1 1 Reproductive Health 2 2 Belize 20 (100)% % % HIV & TB 16 (100)% Reproductive Health 4 (100)% Costa Rica 39 48 83 73 % 1% % HIV & TB 12 15 25 73% Reproductive Health 27 34 58 73% 1% Dominica % % % HIV & TB Reproductive Health Dominican Republic 592 1,071 1,117 4 % 19% % HIV & TB 329 599 621 4% 11% Reproductive Health 260 473 491 4% 8% Child Survival 3 5 Dominican Republic Panam 12 66 28,655 % 1% % Child Survival 12 66 28,655% 1% El Salvador 378 141 932 561 % 16% % HIV & TB 61 57 276 385% 5% Reproductive Health 317 84 656 68 11% Grenada % % % HIV & TB Reproductive Health Guatemala 1,027 368 1,485 303 % 26% % HIV & TB 263 165 371 125% 6% Reproductive Health 764 204 1,114 447% 19% Honduras 156 255 276 8 % 5% % HIV & TB 79 129 140 8% 2% Reproductive Health 77 126 136 8% 2% Mexico 16 6 31 388 % 1% % HIV & TB 11 2 21 773% Reproductive Health 5 4 10 147% Nicaragua 336 482 665 38 % 11% % HIV & TB 78 149 142 (5)% 2% Reproductive Health 258 333 523 57% 9% 3006 3/23/ 4:32:30PM Page 4 of 6 7

Monthly DALY Report by Country Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved Panama 181 368 503 37 % 9% % HIV & TB 112 229 313 37% 5% Reproductive Health 68 139 190 37% 3% Paraguay 436 429 623 45 % 11% % HIV & TB 39 101 94 (7)% 2% Reproductive Health 398 328 529 61% 9% St. Kitss % % % HIV & TB Reproductive Health St. Lucia 1 1 % % % HIV & TB Reproductive Health 1 1 St. Martin % % % HIV & TB Reproductive Health St. Vincent % % % HIV & TB Reproductive Health Suriname 1 1 % % % HIV & TB Reproductive Health 1 1 Trinidad 2 2 % % % HIV & TB Reproductive Health 1 1 Asia and Eastern Europe 64,551 146,411 123,696 (16%) 10 % Cambodia 8,240 13,491 10,632 (21)% 9% % HIV & TB 3,643 4,170 4,187 3% Reproductive Health 2,436 3,308 2,796 (15)% 2% Malaria Control 2,066 6,013 3,554 (41)% 3% Child Survival 95 96 China 30 258 85 (67)% % % HIV & TB 4 23 11 (51)% Reproductive Health 24 125 61 (51)% Malaria Control 1 110 13 (88)% India 22,992 47,109 35,278 (25)% 29% % HIV & TB 3,065 6,620 5,003 (24)% 4% Reproductive Health 19,247 35,724 29,574 (17)% 24% Child Survival 681 4,765 702 (85)% 1% Kazakhstan 192 36 243 575 % % % HIV & TB 9 6 15 16 Reproductive Health 183 30 229 651% Kyrgyzstan 37 195 232 19 % % % HIV & TB 3 (100)% Reproductive Health 37 192 232 21% Laos 78 330 250 (24)% % % HIV & TB 21 139 101 (28)% 3006 3/23/ 4:32:30PM Page 5 of 6 8

Monthly DALY Report by Country Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved Reproductive Health 57 122 150 22% Malaria Control 68 (100)% Myanmar 6,943 14,192 14,955 5 % 12% % HIV & TB 3,536 9,429 7,503 (20)% 6% Reproductive Health 2,059 3,426 4,444 3 4% Malaria Control 897 486 2,123 337% 2% Child Survival 450 851 885 4% 1% Nepal 4,853 1,450 4,866 236 % 4% % Reproductive Health 4,853 1,386 4,866 251% 4% Malaria Control Child Survival 64 (100)% Pakistan 20,630 67,842 55,944 (18)% 45% % HIV & TB 509 4,928 1,266 (74)% 1% Reproductive Health 20,104 61,184 53,481 (13)% 43% Child Survival 17 1,730 1,196 (31)% 1% Papua New Guinea 19 20 21 1 % % HIV & TB 11 10 12 11% Reproductive Health 9 9 10 9% Romania 7 188 109 (42)% % % HIV & TB 2 43 25 (42)% Reproductive Health 6 145 84 (42)% Russia % % % HIV & TB Reproductive Health Tajikistan 27 139 97 (30)% % % HIV & TB 7 (100)% Reproductive Health 27 132 97 (26)% Thailand 123 37 142 289 % % % HIV & TB 118 14 131 829% Reproductive Health 5 22 11 (50)% Vietnam 377 1,126 840 (25)% 1% % HIV & TB 173 491 390 (21)% Reproductive Health 204 588 451 (23)% Child Survival 46 (100)% 3006 3/23/ 4:32:30PM Page 6 of 6 9

Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE Basic Care Package 72,433 50,222 73,484 2,160 3,302% 352,708 639,500 29,897 East Africa 72,433 50,222 73,484 2,160 3,302% 352,708 639,500 29,897 BCC (Behavior Change) 42 42 17,237 (100)% 25,951 26,755 Asia and Eastern Europe 42 42 17,237 (100)% 25,951 26,755 Clean Delivery Kit 1,629 7,989 11,266 53,937 (79)% 176,606 878,444 485 West and Central Africa 261 309 411 8,989 (95)% 32,548 130,966 23 East Africa 1,268 736 2,755 815 238% 5,632 162,525 154 Asia and Eastern Europe 100 6,943 8,100 44,133 (82)% 138,426 584,953 309 Condom 74,019,450 87,396,213 140,439,334 149,229,808 (6)% 1,012,452,642 9,400,616,743 550,307 West and Central Africa 25,597,436 26,751,800 45,374,624 50,935,344 (11)% 328,056,799 2,933,126,852 176,254 East Africa 12,253,628 11,508,408 24,085,704 24,850,103 (3)% 153,410,168 1,216,720,862 148,737 Southern Africa 11,617,678 11,006,940 23,033,509 22,898,380 1% 133,173,437 681,550,576 169,075 Americas 3,490,217 3,906,007 7,088,055 4,814,956 47% 41,651,106 245,188,657 4,056 Asia and Eastern Europe 21,060,491 34,223,058 40,857,442 45,731,025 (11)% 356,161,132 4,324,029,796 52,185 Deworming Tablets 8,632 61,399 17,164 5,850 193% 490,581 577,757 East Africa 8,632 58,562 14,264 % 445,461 459,725 Southern Africa 2,837 2,900 5,850 (50)% 45,120 118,032 Diarrhea Treatment Kit 109,247 59,257 172,949 27,254 535% 775,150 1,257,615 3,652 West and Central Africa 22,050 13,462 34,370 26,544 29% 251,448 595,334 1,032 East Africa 39,124 8,441 49,024 % 140,863 189,887 1,472 Southern Africa 5,542 4,233 18,242 50 36,384% 27,424 45,666 548 Asia and Eastern Europe 42,531 33,121 71,313 660 10,705% 355,415 426,728 599 Emergency Contraception 171,675 266,056 403,918 459,852 (12)% 2,587,817 10,507,206 2,877 West and Central Africa 84,960 113,580 193,440 159,420 21% 1,057,457 5,202,171 1,789 Southern Africa 1,940 8,873 16,887 % 26,852 198,740 156 Americas 11,311 15,777 25,007 21,659 15% 131,270 494,171 37 Asia and Eastern Europe 73,464 127,825 168,584 278,773 (40)% 1,372,238 4,612,124 895 Female Condom 495,945 404,792 791,682 1,112,971 (29)% 5,646,218 26,129,666 4,365 3004 3/23/ 4:36:27PM 10 Page 1 of 9

Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE West and Central Africa 123,929 177,566 262,440 111,789 135% 1,374,466 4,537,035 968 East Africa 117,009 24,059 130,334 244,803 (47)% 941,350 2,738,386 809 Southern Africa 223,749 158,875 347,496 672,100 (48)% 2,852,687 17,494,770 2,531 Americas 3,710 1,853 4,710 3,393 39% 55,089 161,137 2 Asia and Eastern Europe 27,548 42,439 46,702 80,886 (42)% 422,626 1,198,338 55 Free Condom 5,231,404 14,026,773 7,224,823 11,880,325 (39)% 160,612,610 566,955,360 27,668 West and Central Africa 1,012,112 1,011,674 1,180,303 225,852 423% 9,367,941 37,596,276 3,592 East Africa 3,230,352 2,480,124 4,607,179 6,279,534 (27)% 51,577,069 111,299,683 17,106 Southern Africa 713,845 10,137,370 1,098,205 4,374,264 (75)% 93,847,880 402,711,190 6,761 Americas 20,196 52,756 37,332 16,533 126% 298,150 646,492 14 Asia and Eastern Europe 254,899 344,849 301,804 984,142 (69)% 5,521,570 14,701,719 195 Free Female Condom 26,852 75,299 85,545 8,334 926% 246,312 374,092 460 West and Central Africa % 3,600 3,600 East Africa 23,750 53,197 80,914 % 127,537 208,451 447 Southern Africa 2,200 16,411 2,200 1,729 27% 65,291 95,986 12 Americas 857 3,674 879 55 1,498% 12,308 18,511 Asia and Eastern Europe 45 2,017 1,552 6,550 (76)% 37,576 47,544 1 Implant 3 276 2,195 408 2,058 (80)% 14,522 25,250 167 East Africa 192 1,227 192 % 3,681 3,873 94 Southern Africa 127 131 55 138% 907 1,776 64 Asia and Eastern Europe 84 841 85 2,003 (96)% 9,934 19,601 10 Implant 5 11,349 10,162 20,047 5,277 28 109,971 132,520 14,852 West and Central Africa 6,976 6,165 12,548 1,272 886% 20,043 34,510 9,903 East Africa 410 1,092 741 4,000 (81)% 32,244 33,134 585 Southern Africa 2,843 2,147 5,042 % 43,763 49,059 3,979 Americas 378 262 748 5 14,86 7,245 8,173 95 Asia and Eastern Europe 742 495 968 % 6,676 7,644 290 Infant Fortified Food % 56,625 91,859 3004 3/23/ 4:36:46PM 11 Page 2 of 9

Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE Asia and Eastern Europe % 56,625 91,859 Injectable 1 36,262 35,880 69,923 77,511 (10)% 381,893 1,726,368 584 West and Central Africa 5,900 4,523 9,800 400 2,35 10,091 70,277 180 Americas 4,010 3,139 6,795 % 28,952 49,747 20 Asia and Eastern Europe 26,352 28,217 53,328 77,111 (31)% 342,850 1,606,344 384 Injectable 2 81,240 146,625 203,900 205,342 (1)% 1,286,258 10,825,543 6,454 West and Central Africa 33,000 98,758 103,800 100,100 4% 815,099 7,059,755 4,138 Asia and Eastern Europe 48,240 47,867 100,100 105,242 (5)% 471,159 3,765,788 2,316 Injectable 3 323,333 417,946 695,895 480,804 45% 4,169,178 25,230,936 31,130 West and Central Africa 147,244 128,836 211,467 271,973 (22)% 2,075,381 12,222,745 11,843 East Africa 30,390 49,173 118,438 45,250 162% 216,548 1,619,865 7,083 Southern Africa 6,621 96,012 115,620 42,250 174% 682,445 4,851,249 6,915 Americas 370 15,000 5,370 % 40,000 45,370 52 Asia and Eastern Europe 138,708 128,924 245,000 121,331 102% 1,154,804 6,491,707 5,237 Iron Folic Acid Tablet 249,600 112,270 441,600 468,000 (6)% 2,546,400 39,386,610 471 Asia and Eastern Europe 249,600 112,270 441,600 468,000 (6)% 2,546,400 39,386,610 471 ITN 36,770 217,022 642,124 101,196 535% 922,996 17,119,873 139,775 West and Central Africa 1,202 202,035 588,569 1,603 36,617% 541,136 1,443,877 128,118 East Africa 35,568 14,892 53,555 99,593 (46)% 239,127 15,533,263 11,658 Southern Africa 95 % 142,733 142,733 IUD 80,893 63,268 136,776 79,397 72% 618,082 3,148,757 71,832 West and Central Africa 24,121 6,209 28,461 9,235 208% 73,576 1,067,844 22,738 East Africa 4,510 6,586 6,039 1,660 264% 44,704 51,567 4,825 Southern Africa 2,028 3,150 4,051 852 375% 25,515 37,114 3,236 Americas 5,380 1,626 7,269 300 2,323% 26,484 33,831 932 Asia and Eastern Europe 44,854 45,698 90,956 67,350 35% 447,803 1,958,401 40,101 LLIN 84,546 1,861,633 115,795 1,035,330 (89)% 11,233,502 34,505,043 37,061 West and Central Africa 24,502 1,175,237 40,586 633,279 (94)% 5,663,766 18,555,307 13,057 3004 3/23/ 4:36:46PM 12 Page 3 of 9

Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE East Africa 58,286 377,698 70,424 284,364 (75)% 3,636,432 10,366,115 22,656 Southern Africa 1,692 308,448 4,150 107,977 (96)% 1,546,970 4,502,580 1,335 Asia and Eastern Europe 66 251 635 9,710 (93)% 386,334 1,081,041 13 Lubricant A 387,473 532,824 548,932 352,752 56% 3,717,274 20,993,883 Americas 46,520 15,762 66,196 29,259 126% 150,909 934,237 Asia and Eastern Europe 340,953 517,062 482,736 323,493 49% 3,566,365 20,059,646 Lubricant B 4,418 14,897 9,240 9,634 (4)% 102,056 246,231 Asia and Eastern Europe 4,418 14,897 9,240 9,634 (4)% 102,056 246,231 Lubricant C 2,253 1,873 5,678 3,992 42% 15,038 49,222 West and Central Africa 2,253 1,869 5,678 3,692 54% 14,724 46,853 Americas 4 300 (100)% 314 2,369 Lubricant E 3,890 3,301 7,939 28,238 (72)% 123,999 628,816 West and Central Africa 847 24,289 (100)% 95,313 528,836 Americas 3,890 2,453 7,939 3,949 101% 28,686 99,980 Malaria PPT (ACT) 491,917 726,245 765,684 1,100,470 (30)% 9,379,305 14,809,606 51,542 West and Central Africa 412,439 411,565 648,981 952,438 (32)% 7,324,018 11,290,209 44,187 East Africa 51,660 265,127 59,010 8,640 583% 1,179,613 1,242,793 4,018 Southern Africa 12,690 27,120 33,520 75,964 (56)% 519,338 841,779 2,282 Asia and Eastern Europe 15,128 22,433 24,173 63,428 (62)% 356,336 1,434,825 1,055 Malaria RDK 14,480 18,760 32,880 81,341 (60)% 533,320 2,144,657 1,430 Asia and Eastern Europe 14,480 18,760 32,880 81,341 (60)% 533,320 2,144,657 1,430 Male Circumcision (HIVNegative) 1,017 2,272 2,948 479 515% 14,430 19,328 8,668 Southern Africa 1,017 2,272 2,948 479 515% 14,430 19,328 8,668 Male Circumcision (HIVUnknown) 92 1,044 983 216 355% 5,699 7,102 2,021 Southern Africa 92 1,044 983 216 355% 5,699 7,102 2,021 Medical Abortion 10,990 8,893 14,935 10,800 38% 46,908 61,843 1,763 Southern Africa % 10,445 10,445 Asia and Eastern Europe 10,990 8,893 14,935 10,800 38% 36,463 51,398 1,763 3004 3/23/ 4:36:46PM 13 Page 4 of 9

Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE Misoprostol 36,990 41,637 61,600 % 460,931 522,531 939 East Africa 21,990 26,837 40,600 % 285,410 326,010 619 Southern Africa 15,000 14,800 21,000 % 175,521 196,521 320 Multivitamin 377,160 225,920 619,530 454,100 36% 2,580,320 36,138,508 300 West and Central Africa 92,400 35,850 118,830 177,750 (33)% 566,190 12,973,058 143 Americas 284,760 190,070 500,700 274,350 83% 1,982,130 20,517,960 157 Asia and Eastern Europe 2,000 (100)% 32,000 2,647,490 Needle & Syringe 36,101 2,858 41,476 % 34,800 76,276 140 Americas 2,900 1,967 5,600 % 16,800 22,400 15 Asia and Eastern Europe 33,201 892 35,876 % 18,000 53,876 125 Netprotect 10,000 52,348 23,502 % 265,650 289,152 7,561 East Africa 10,000 52,348 23,502 % 265,650 289,152 7,561 NVP (Mother and Baby) 645 (100)% 645 8,635 East Africa 645 (100)% 645 8,635 NVP (Mother Only) 354 (100)% 354 2,422 East Africa 354 (100)% 354 2,422 OCs 1,754,413 2,488,617 3,261,008 4,292,195 (24)% 30,187,839 185,201,507 39,299 West and Central Africa 699,476 614,983 1,259,036 1,502,437 (16)% 8,727,474 43,415,184 17,888 East Africa 223,330 226,848 444,634 412,559 8% 2,402,606 12,417,301 6,725 Southern Africa 188,314 447,390 532,134 486,170 9% 4,309,120 25,964,738 8,049 Americas 120,597 29,260 138,156 65,205 112% 518,649 2,517,758 335 Asia and Eastern Europe 522,696 1,170,137 887,048 1,825,824 (51)% 14,229,990 100,886,526 6,300 Olyset 289,204 872,266 558,161 840,287 (34)% 6,835,321 15,097,901 179,568 West and Central Africa 480 96,676 3,887 % 1,384,180 2,270,191 1,251 East Africa 288,724 269,375 485,140 800,693 (39)% 3,452,724 10,557,136 156,076 Southern Africa 506,216 69,134 39,594 75% 1,998,417 2,270,574 22,241 ORS 587,555 230,289 683,285 945,034 (28)% 4,801,600 89,523,735 8,236 West and Central Africa 337,996 133,420 370,636 222,652 66% 1,370,742 59,140,071 4,060 3004 3/23/ 4:36:46PM 14 Page 5 of 9

Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE East Africa 188,352 86,872 249,192 248,112 % 1,138,068 12,465,071 3,582 Asia and Eastern Europe 61,207 9,997 63,457 474,270 (87)% 2,292,790 17,918,593 594 Pneumonia PPT 14,645 12,788 28,433 64,050 (56)% 136,084 277,193 333 East Africa 37,250 (100)% 37,250 77,300 Asia and Eastern Europe 14,645 12,788 28,433 26,800 6% 98,834 199,893 333 Pregnancy Test 2,820 3,359 6,585 6,485 2% 34,543 96,663 Asia and Eastern Europe 2,820 3,359 6,585 6,485 2% 34,543 96,663 PUR 2,338,986 3,317,688 4,499,737 1,561,716 188% 30,104,720 83,953,739 593 West and Central Africa 164,156 459,173 254,831 574,919 (56)% 4,947,034 9,881,342 45 East Africa 1,785,303 2,298,989 2,630,069 746,525 252% 19,915,992 53,250,417 473 Southern Africa 1,440 (100)% 1,133,600 1,272,762 Americas 365,760 408,160 1,580,640 4,800 32,83 412,560 5,846,880 71 Asia and Eastern Europe 23,767 151,366 34,197 234,032 (85)% 3,695,534 13,702,338 3 Retreatment 40,546 82,327 98,748 79,774 24% 652,924 16,112,919 720 West and Central Africa 3,488 (100)% 22,653 1,009,438 East Africa 5,641 24,180 12,901 3,980 224% 207,000 13,043,286 510 Asia and Eastern Europe 34,905 58,147 85,847 72,306 19% 423,271 2,060,195 210 Retreatment IconMaxx 115,400 157,135 243,001 % 2,312,784 2,555,785 10,854 East Africa 4,200 86,333 34,200 % 2,197,980 2,232,180 7,873 Asia and Eastern Europe 111,200 70,802 208,801 % 114,804 323,605 2,981 Retreatment KO123 522 33,911 9,856 292,282 (97)% 3,969,863 8,486,037 2,269 West and Central Africa 522 439 844 844 % 2,585 3,429 194 East Africa 33,472 9,012 291,438 (97)% 3,967,278 8,482,608 2,075 Retreatment KO123 net 31,000 67,333 151,000 321,762 (53)% 1,053,127 9,293,890 48,579 East Africa 31,000 67,333 151,000 321,762 (53)% 1,053,127 9,293,890 48,579 Safe Water Solution 1,119,532 1,320,208 1,795,989 2,972,540 (40)% 16,585,068 67,497,896 30,940 West and Central Africa 66,791 140,064 133,031 132,535 % 2,461,931 7,999,171 1,898 East Africa 541,581 689,518 858,891 1,638,173 (48)% 8,172,291 30,750,420 15,440 3004 3/23/ 4:36:46PM 15 Page 6 of 9

Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE Southern Africa 495,196 459,528 776,561 976,323 (20)% 4,644,608 25,022,409 13,445 Asia and Eastern Europe 15,964 31,098 27,506 225,509 (88)% 1,306,238 3,725,896 157 SDM (Cycle Beads) 2,380 2,058 3,688 4,015 (8)% 38,395 119,264 1,578 West and Central Africa 800 1,303 1,166 2,403 (51)% 19,368 81,453 499 Southern Africa 1,580 755 2,522 1,612 56% 19,027 37,811 1,079 Sprinkles 2,275 79,177 182,905 901,950 (80)% 1,912,110 5,052,029 1,193 Southern Africa 640,350 (100)% 653,400 1,007,220 Asia and Eastern Europe 2,275 79,177 182,905 261,600 (30)% 1,258,710 4,044,809 1,193 STI Kit 6,011 33,807 36,666 83,276 (56)% 537,804 3,482,810 1,481 West and Central Africa % 2,055 5,004 East Africa 8,180 (100)% 8,920 30,191 Southern Africa 22,816 21,045 51,460 (59)% 395,336 2,751,740 1,072 Asia and Eastern Europe 6,011 10,992 15,621 23,636 (34)% 131,493 695,875 409 TB DOTS 408 1,358 979 3,586 (73)% 23,236 113,033 4,020 Asia and Eastern Europe 408 1,358 979 3,586 (73)% 23,236 113,033 4,020 VCT Concordant Couple (HIVNegative) 7,290 6,136 15,716 % 9,982 25,698 2,157 West and Central Africa 892 267 1,550 % 142 1,692 39 East Africa 1,396 695 2,510 % 972 3,482 357 Southern Africa 4,828 5,055 11,354 % 8,638 19,992 1,759 Asia and Eastern Europe 174 119 302 % 230 532 2 VCT Concordant Couple (HIVPositive) 848 1,060 2,452 % 1,576 4,028 1,480 West and Central Africa 6 3 12 % 2 14 1 East Africa 60 54 128 % 94 222 73 Southern Africa 738 959 2,218 % 1,398 3,616 1,403 Asia and Eastern Europe 44 44 94 % 82 176 3 VCT Couple 3,165 24,801 (100)% 103,515 304,536 West and Central Africa 295 1,474 (100)% 8,708 29,424 East Africa 311 2,536 (100)% 13,646 50,850 3004 3/23/ 4:36:46PM 16 Page 7 of 9

Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE Southern Africa 2,477 20,533 (100)% 79,005 217,528 Asia and Eastern Europe 83 258 (100)% 2,156 6,734 VCT Discordant Couple (HIVNegative) 452 71 572 % 94 666 148 West and Central Africa 27 9 49 % 6 55 2 East Africa 29 23 62 % 36 98 17 Southern Africa 374 24 421 % 24 445 129 Asia and Eastern Europe 22 15 40 % 28 68 1 VCT Discordant Couple (HIVPositive) 452 71 572 % 94 666 362 West and Central Africa 27 9 49 % 6 55 5 East Africa 29 23 62 % 36 98 40 Southern Africa 374 24 421 % 24 445 315 Asia and Eastern Europe 22 15 40 % 28 68 2 VCT Individual (HIVNegative) 77,575 125,809 153,690 % 301,312 455,002 16,698 West and Central Africa 21,168 80,993 43,350 % 220,798 264,148 860 East Africa 7,648 3,622 12,939 % 5,575 18,514 1,841 Southern Africa 44,092 36,656 88,064 % 65,996 154,060 13,954 Americas 397 706 502 % 2,013 2,515 2 Asia and Eastern Europe 4,270 3,832 8,835 % 6,930 15,765 40 VCT Individual (HIVPositive) 10,134 14,714 22,320 % 31,957 54,277 13,033 West and Central Africa 1,695 6,785 2,752 % 19,298 22,050 239 East Africa 894 604 1,621 % 1,084 2,705 919 Southern Africa 7,287 7,095 17,475 % 11,098 28,573 11,861 Americas 4 7 6 % 20 26 Asia and Eastern Europe 254 223 466 % 457 923 14 VCT Single 30,255 230,630 (100)% 1,168,927 4,459,590 West and Central Africa 12,961 40,289 (100)% 282,286 806,846 East Africa 2,221 28,984 (100)% 120,129 879,945 Southern Africa 13,633 154,807 (100)% 714,612 2,588,714 3004 3/23/ 4:36:46PM 17 Page 8 of 9

Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE Americas (26) % 4,184 5,460 Asia and Eastern Europe 1,467 6,550 (100)% 47,716 178,625 VSC 6,875 (100)% 22,253 129,797 Asia and Eastern Europe 6,875 (100)% 22,253 129,797 Water Treatment Tablets 3,227,601 6,151,549 7,294,001 15,174,043 (52)% 77,229,926 171,217,243 2,925 West and Central Africa 313,341 354,302 676,519 485,920 39% 5,915,851 7,417,010 268 East Africa 2,225,810 1,356,347 3,682,032 9,612,009 (62)% 33,224,337 102,431,339 1,433 Southern Africa 582,000 4,405,733 2,810,600 5,076,114 (45)% 38,002,638 61,156,944 1,223 Asia and Eastern Europe 106,450 35,167 124,850 % 87,100 211,950 Water Vessel 9,446 5,053 12,104 13,108 (8)% 148,935 1,219,271 East Africa 7,768 5,053 10,426 13,108 (20)% 148,933 410,735 Southern Africa % 2 803,251 Asia and Eastern Europe 1,678 1,678 % 5,285 Zinc 200,960 (100)% 393,030 548,675 East Africa 900 (100)% 18,600 74,243 Asia and Eastern Europe 200,060 (100)% 374,430 474,432 3004 3/23/ 4:36:46PM 18 Page 9 of 9

West & Central Africa

CYPs, Cases, and Deaths by Country 1/ 2/ HIV & TB Reproductive Health Malaria Control Child Survival Cases STI Deaths TB Deaths CYP Maternal Deaths Unintended Pregnancies Malaria Cases Malaria Deaths Diarrhea Cases Diarrhea Deaths Nutrition Deaths Pneumonia Cases Pneumonia Deaths Sum of All Deaths West and Central Africa 5,012 631,675 1,085 186,796 634,981 5,958 57,732 232 7,275 Benin 115 27,648 48 8,231 3 2,878 146 194 Burkina Faso 199 25,707 45 7,653 45 Burundi 6 608 1 181 5,452 40 1,180 2 42 C.A.R. 17 5 Cameroon 454 32,076 56 9,549 6,999 51 8 115 CongoKinshasa 546 60,575 106 18,033 1,786 56 1,490 2 164 Cote d'ivoire 17 904 2 269 787 6 1,749 13 20 Guinea 13 26,808 47 7,981 7,563 10 56 Haiti 8 10,156 1 1,773 6,382 6 7 Liberia 1 2,604 3 3 Mali 87 53,119 92 15,813 180 1 1,235 2 95 Nigeria 3,237 349,703 608 104,105 61,893 1,475 28,273 36 2,118 Rwanda 132 9,235 16 2,749 555,476 4,312 4,377 6 4,333 Togo 199 35,118 65 10,454 2,405 18 82 19 3001 3/23/ 4:30:13PM Page 1 of 5

Monthly Distribution by Region and Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE SALES HIV NonHIV West and Central Africa All 97,259 347,955 445,214 Clean Delivery Kit 261 309 411 8,989 (95)% 32,548 130,966 23 23 Condom 25,597,436 26,751,800 45,374,624 50,935,344 (11)% 328,056,799 2,933,126,852 93,731 82,523 176,254 Diarrhea Treatment Kit 22,050 13,462 34,370 26,544 29% 251,448 595,334 1,032 1,032 Emergency Contraception 84,960 113,580 193,440 159,420 21% 1,057,457 5,202,171 1,789 1,789 Female Condom 123,929 177,566 262,440 111,789 135% 1,374,466 4,537,035 511 457 968 Free Condom 1,012,112 1,011,674 1,180,303 225,852 423% 9,367,941 37,596,276 1,871 1,720 3,592 Free Female Condom % 3,600 3,600 Implant 5 6,976 6,165 12,548 1,272 886% 20,043 34,510 9,903 9,903 Injectable 1 5,900 4,523 9,800 400 2,35 10,091 70,277 180 180 Injectable 2 33,000 98,758 103,800 100,100 4% 815,099 7,059,755 4,138 4,138 Injectable 3 147,244 128,836 211,467 271,973 (22)% 2,075,381 12,222,745 11,843 11,843 ITN 1,202 202,035 588,569 1,603 36,617% 541,136 1,443,877 128,118 128,118 IUD 24,121 6,209 28,461 9,235 208% 73,576 1,067,844 22,738 22,738 LLIN 24,502 1,175,237 40,586 633,279 (94)% 5,663,766 18,555,307 13,057 13,057 Lubricant C 2,253 1,869 5,678 3,692 54% 14,724 46,853 Lubricant E 847 24,289 (100)% 95,313 528,836 Malaria PPT (ACT) 412,439 411,565 648,981 952,438 (32)% 7,324,018 11,290,209 44,187 44,187 Multivitamin 92,400 35,850 118,830 177,750 (33)% 566,190 12,973,058 143 143 OCs 699,476 614,983 1,259,036 1,502,437 (16)% 8,727,474 43,415,184 17,888 17,888 Olyset 480 96,676 3,887 % 1,384,180 2,270,191 1,251 1,251 ORS 337,996 133,420 370,636 222,652 66% 1,370,742 59,140,071 4,060 4,060 PUR 164,156 459,173 254,831 574,919 (56)% 4,947,034 9,881,342 45 45 20 3003 3/23/ 4:35:09PM Page 1 of 13

Monthly Distribution by Region and Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE SALES HIV NonHIV Retreatment 3,488 (100)% 22,653 1,009,438 Retreatment KO123 522 439 844 844 % 2,585 3,429 194 194 Safe Water Solution 66,791 140,064 133,031 132,535 % 2,461,931 7,999,171 1,898 1,898 SDM (Cycle Beads) 800 1,303 1,166 2,403 (51)% 19,368 81,453 499 499 STI Kit % 2,055 5,004 VCT Concordant Couple (HIV 892 267 1,550 % 142 1,692 39 39 VCT Concordant Couple (HIV 6 3 12 % 2 14 1 1 VCT Couple 295 1,474 (100)% 8,708 29,424 VCT Discordant Couple (HIVN 27 9 49 % 6 55 2 2 VCT Discordant Couple (HIVP 27 9 49 % 6 55 5 5 VCT Individual (HIVNegative) 21,168 80,993 43,350 % 220,798 264,148 860 860 VCT Individual (HIVPositive) 1,695 6,785 2,752 % 19,298 22,050 239 239 VCT Single 12,961 40,289 (100)% 282,286 806,846 Water Treatment Tablets 313,341 354,302 676,519 485,920 39% 5,915,851 7,417,010 268 268 21 3003 3/23/ 4:35:29PM Page 2 of 13